Bank of New York Mellon’s CG Oncology CGON Stock Holding History

Bank of New York Mellon's CGON Position: Q2 2026 in Review

Bank of New York Mellon increased its CG Oncology (CGON) stake by 40% in Q2 2026, buying an estimated $4.34M and bringing the position to 233,419 shares worth $16.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Bank of New York Mellon first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 111 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

• Bank of New York Mellon held 233,419 shares of CG Oncology worth $16.6M as of Q2 2026.
• Bank of New York Mellon bought 66,389 CG Oncology shares in Q2 2026, an estimated $4.34M.
• CG Oncology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1743 holding.
• Bank of New York Mellon first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
• 111 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.